Read an interview with Marianne Takki, Head of Unit for Disease Prevention and Health Promotion at the European Commission

As COVID-19 transitions from a pandemic to an endemic disease, its integration into the broader policy and healthcare framework for respiratory diseases becomes imperative.

With the contribution of the European Association of Preventive Cardiology (EAPC), the Association for Acute CardioVascular Care (ACVC), and the Heart Failure Association (HFA) of the ESC

Cardiovascular diseases remain the leading cause of death in the EU, claiming 1.7 million lives lost each year.

This study is interested in global vaccine confidence because it directly impacts vaccination rates and public health outcomes, especially during the COVID-19 pandemic.

This first episode positions life course immunisation within the global health landscape, framing it alongside the UN Sustainable Development Goals, the WHO European Immunisation Agenda 2030 and broader health equity aims.

What are the causes for the steady and at times dramatic decline in vaccine confidence seen since the mid-90’s across certain age-groups and communities? Why has the public discourse changed?

Outbreaks of vaccine-preventable diseases are increasing at a time when funding for immunisation programmes is being cut.